The contribution of hybrid SPECT/CT imaging in the management of differentiated thyroid carcinoma

被引:4
作者
Mhiri, A. [1 ,2 ]
Slim, I. [1 ,2 ]
Ghezaiel, M. [1 ,2 ]
Meddeb, I. [1 ,2 ]
El Bez, I. [1 ,2 ]
Yeddes, I. [1 ,2 ]
Gritli, S. [1 ]
Ben Slimene, M. F. [1 ,2 ]
机构
[1] Univ Tunis El Manar, Fac Med Tunis, Tunis 1007, Tunisia
[2] Inst Salah Azaiez, Serv Med Nucl, Tunis 1006, Tunisia
来源
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2012年 / 36卷 / 10期
关键词
Differentiated thyroid carcinoma; SPECT/CT; Planar scintigraphy; Iodine; 131; COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY; FOLLOW-UP; CT; IMPACT; PATIENT; IMAGES; FUSION;
D O I
10.1016/j.mednuc.2012.08.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction. Single photon emission computed tomography combined with a low dose computed tomography (SPECT/CT), is a hybrid imaging integrating functional and anatomical data. The purpose of our study was to evaluate the contribution of the SPECT/CT over traditional planar imaging of patients with differentiated thyroid carcinoma (DTC). Methods. Post-therapy iodine 131 (I-131) whole-body scan followed by cervico-thoracic SPECT/CT, were performed in 100 patients with DTC. Results. Among these 100 patients followed for a predominantly papillary DTC, planar imaging and SPECT/CT, were perfectly concordant in 70% of patients and discordant in the remaining 30%. The use of fusion imaging SPECT/CT compared to conventional planar imaging allowed us to correct our therapeutic approach in 27% (27/100 patients), according to the protocols of therapeutic management of our institute. Conclusion. SPECT/CT is a hybrid imaging modality which provides better identification and more correct anatomic localization of the foci of radioiodine uptake with impact on therapeutic management. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 50 条
[41]   Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy [J].
Zilioli, Valentina ;
Peli, Alessia ;
Panarotto, Maria Beatrice ;
Magri, Giancarlo ;
Alkraisheh, Ahmed ;
Wiefels, Christiane ;
Rodella, Carlo ;
Giubbini, Raffaele .
ENDOCRINE, 2017, 56 (03) :551-559
[42]   The future of hybrid imaging-part 1: hybrid imaging technologies and SPECT/CT [J].
Beyer, Thomas ;
Freudenberg, Lutz S. ;
Townsend, David W. ;
Czernin, Johannes .
INSIGHTS INTO IMAGING, 2011, 2 (02) :161-169
[43]   SPECT/CT and tumour imaging [J].
Abikhzer, Gad ;
Keidar, Zohar .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 :S67-S80
[44]   Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma [J].
Yamamoto, Y ;
Nishiyama, Y ;
Monden, T ;
Matsumura, Y ;
Satoh, K ;
Ohkawa, M .
JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (12) :1905-1910
[45]   Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer [J].
Van Nostrand, Douglas .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2017, 46 (03) :783-+
[46]   Differentiated thyroid carcinoma: defining new paradigms for postoperative management [J].
Durante, Cosimo ;
Costante, Giuseppe ;
Filetti, Sebastiano .
ENDOCRINE-RELATED CANCER, 2013, 20 (04) :R141-R154
[47]   18F-FDG PET/CT IN DIFFERENTIATED THYROID CARCINOMA [J].
Larg, M. I. ;
Barbus, E. ;
Gabora, K. ;
Pestean, C. ;
Cheptea, M. ;
Piciu, D. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (02) :203-208
[48]   Hybrid Imaging with SPECT/CT and SPECT/MRI in Hepatic Splenosis [J].
Djekidel, Mehdi ;
Michalski, Mark .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (02) :179-181
[49]   Use of SPECT/CT and PET/CT for epithelial thyroid cancers [J].
Giraudet, A. -L. .
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (03) :179-183
[50]   Impact of 131I SPECT/Spiral CT on Nodal Staging of Differentiated Thyroid Carcinoma at the First Radioablation [J].
Schmidt, Daniela ;
Szikszai, Attila ;
Linke, Rainer ;
Bautz, Werner ;
Kuwert, Torsten .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) :18-23